Composition
- Active ingredients
- REPAGLINIDE 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- REPAGLINIDE 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA020741-003 · Discontinued
- REPAGLINIDE 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA020741-001 · Discontinued
- REPAGLINIDE 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA020741.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Prandin
- Active substance
- repaglinide
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Gemini Labs LLC
- Status
- Discontinued
- FDA approval
- 22 Dec 1997
- Application
- NDA020741-002